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ABSTRACT
Identifying novel players of the pluripotency gene regulatory network centered on Oct4, Sox2,
and Nanog as well as delineating the interactions within the complex network is key to under-
standing self-renewal and early cell fate commitment of embryonic stem cells (ESC). While over-
expression of the transcriptional regulator Cited2 sustains ESC pluripotency, its role in ESC
functions remains unclear. Here, we show that Cited2 is important for proliferation, survival,
and self-renewal of mouse ESC. We position Cited2 within the pluripotency gene regulatory net-
work by deﬁning Nanog, Tbx3, and Klf4 as its direct targets. We also demonstrate that the
defects caused by Cited2 depletion are, at least in part, rescued by Nanog constitutive expres-
sion. Finally, we demonstrate that Cited2 is required for and enhances reprogramming of mouse
embryonic ﬁbroblasts to induced pluripotent stem cells. STEM CELLS 2015;33:699–712
INTRODUCTION
The maintenance of pluripotency of embryonic
stem cells (ESC) is orchestrated by growth fac-
tors and signaling pathways that ultimately
control the optimal expression of the tran-
scription factors Oct4, Sox2, and Nanog, mas-
ter regulators of pluripotency and self-renewal
[1]. In mouse ESC, leukemia inhibitory factor
(LIF) is crucial for pluripotency and activates in
parallel the JAK/Stat3 pathway promoting the
expression of Klf4, an activator of Sox2, and
the PI3K/AKT pathway stimulating Tbx3 expres-
sion which subsequently activates Nanog [2,
3]. The transcriptional coactivators p300 and
CREB-binding protein (CBP) intervene in pluri-
potency and differentiation of mouse ESC, and
p300 is recruited to multiple regulatory
regions of the mouse ESC genome in associa-
tion with Oct4, Sox2, and Nanog [4]. Cited2, a
transcriptional regulator, strongly binds to
p300 and CBP and is essential for mouse
embryonic development [5–9] and the mainte-
nance of fetal and adult hematopoietic stem
cells [10, 11]. Cited2 overexpression, like
ectopic expression of Nanog, sustains self-
renewal of mouse ESC in the absence of LIF
[12, 13]. The mechanisms regulating Cited2
expression in mouse and human ESC are still
poorly understood, but Cited2 transcriptional
regulatory elements are bound by transcrip-
tional factors critical for pluripotency such as
Oct4, Sox2, Nanog, FoxP1, and Zfp206 [14–16].
Here, we establish that acute loss of Cited2
expression in mouse ESC maintained under non-
differentiating conditions results in a rapid
decline of ESC self-renewal and survival. We
demonstrate that Cited2 is present on the regu-
latory elements of Nanog, Klf4, and Tbx3 and
controls their expression in undifferentiated ESC.
The constitutive expression of Cited2 or Nanog
in ESC rescues both self-renewal and survival
defects caused by Cited2 depletion. We there-
fore propose that Cited2 plays an important role
in mouse ESC self-renewal, proliferation, and sur-
vival, at least in part, by directly regulating tran-
scription of Nanog, Klf4, and Tbx3. Finally, we
demonstrate that Cited2 is necessary for the
generation of induced pluripotent stem (iPS)
cells from mouse embryonic ﬁbroblasts (MEFs)
and it enhances MEF reprogramming efﬁciency.
MATERIALS AND METHODS
ESC and Culture Conditions
All ESC lines were cultured on gelatine-coated
plates in undifferentiating medium supple-
mented with LIF [12]. Derivation of mouse
C2ﬂ/ﬂ ESC from Cited2ﬂ/ﬂ blastocysts was per-
formed as described previously [17]. C2ﬂ/ﬂ
[Cre]A, C2ﬂ/ﬂ[Cre]B, and C2ﬂ/ﬂ[Cre]C ESC are
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three independent cell colonies obtained from the stable
transfection of C2ﬂ/ﬂ ESC with the pPyCAGIP-CreERt plasmid
(encoding Cre-ERT2 [18] subcloned into pPyCAGIP).
C2ﬂ/ﬂ[Cre]A, C2ﬂ/ﬂ[Cre]B, and C2ﬂ/ﬂ[Cre]C ESC were expanded
and characterized for their ability to knockout Cited2 upon
treatment with 0.5 or 1 lM of 4-hydroxytamoxifen (4HT).
Similarly E14TG2A[Cre] cells were obtained by stable transfec-
tion of E14TG2A with pPyCAGIP-CreERt. E14/T cells were a
gift from Professor Austin Smith (University of Cambridge,
U.K.) and were described elsewhere [19]. C2ﬂ/ﬂ[Cre]/CITED2
and C2ﬂ/ﬂ[Cre]/Control ESC were, respectively, obtained by
transduction of C2ﬂ/ﬂ[Cre]A or C2ﬂ/ﬂ[Cre]B ESC with lentiviral
particles expressing the human CITED2 peptide and the green
ﬂuorescent protein (GFP) or the control particles expressing
GFP as described elsewhere [11]. C2ﬂ/ﬂ[Cre]/Control and
C2ﬂ/ﬂ[Cre]/CITED2 ESC expressing GFP were isolated by ﬂuo-
rescence activated cell sorting using a FACSAria II Cell Sorter
(BD Bioscience, Erembodegem, Belgium, http://www.bd.com/
scripts/support/search.asp?city=0&country=Belgium&division
Name=0&serviceType=0&state50). C2ﬂ/ﬂ[Cre]/Control and
C2ﬂ/ﬂ[Cre]/CITED2 ESC cells treated with 0.5 or 1 lM of 4HT
were converted into Cited2 knockout cells and named C2D/
D[Cre]/Control and C2D/D[Cre]/CITED2 ESC, respectively. Stable
Cited2 knockout ESC (C2D/D ESC) were obtained after sorting
using a FACSAria II Cell Sorter (BD Bioscience) of GFP-positive
C2ﬂ/ﬂ ESC transiently transfected with a plasmid expressing a
constitutively active Cre recombinase and the GFP. Sorted
GFP-positive cells were grown in culture for approximately 4
weeks before isolation by FACS based on the ﬂuorescence
emitted by the cleavage of ﬂuorescein-di-b-D-galactopyrano-
side into a ﬂuorescein by b-galactosidase expressed in Cited2
knockout cells [20]. Single cells were individually collected in
gelatine-coated 96-well plates containing ESC culture medium.
Six independent colonies were then genotyped using primers
listed in Supporting Information Table S1 to detect Cited2 Cre-
recombined alleles. C2ﬂ/ﬂ/Control and C2ﬂ/ﬂ/Nanog ESC were,
respectively, engineered by stable transfection and puromycin
resistance selection of C2ﬂ/ﬂ ESC with the pPyCAGIP and
pPyCAGIP-Nanog, gifts from Professor Austin Smith (University
of Cambridge, U.K.) described elsewhere [19]. To perform the
knockout, ESC-C2ﬂ/ﬂ/Control and ESC-C2ﬂ/ﬂ/Nanog cells were
transiently transfected with a plasmid expressing the Cre
recombinase and GFP, and sorted based on GFP expression a
day after transfection using a FACSAria II Cell Sorter (BD Bio-
science), and were named C2D/D/Control and C2D/D/Nanog
ESC, respectively.
Cited2 Knockdown
The KD-Cited2 plasmid was constructed by insertion of a 375
bp cDNA fragment corresponding to the amino acids 2–123 of
the human CITED2 at the BamHI of the pDoubNeo vector
[21]. The KD-control vector was constructed by insertion of a
369 bp fragment of the Pol region containing a splice
acceptor site of the Moloney mouse leukemia virus at the
BamHI of the pDoubNeo vector (referred to as KD-empty).
KD-empty, KD-control, and KD-Cited2 were transfected into
E14TG2A and E14/T cells using Lipofectamine 2000 (Invitro-
gen). These cells were maintained in culture in the presence
of G418 at 400 lg/ml for the duration of the experiments to
reduce the presence of untransfected cells. Plasmids used to
express Cited2 shRNA and control shRNA were previously
described [11].
Quantitative Real-Time PCR
Total RNA was isolated using the RNeasy Mini Kit (QIAGEN, Hil-
den, Germany, http://www.qiagen.com/) and used to synthesize
complementary DNA with qScript cDNA SuperMix (Quanta Bio-
Sciences, MD, USA, http://www.quantabio.com/page/contact.
php). Quantitative real-time PCR (qPCR) assays were carried
out in LightCycler LC480 (Roche) or CFX96 (Bio-Rad, Birmingham,
United Kingdom, http://www.bio-rad.com/?WT.srch51&WT.mc_
id5aw-corp-eu-brand&WT.knsh_id5628e3f91-bdaa-d6e8-22d6-
0000734b512f) thermocyclers using SsoFast EvaGreen Supermix
(Bio-Rad) or PerfeCTa SYBR Green (Quanta BioSciences) with pri-
mers listed in Supporting Information Table S1. The primer set
designated Cited2#1 (Supporting Information Table S1) was used
to detect both mouse endogenous Cited2 and human exogenous
ﬂag-CITED2 cDNA in qPCR experiments, except when otherwise
stated. The primer set designated Cited2#2 is speciﬁc for detec-
tion of endogenous mouse Cited2 expression. Expression levels
were normalized to Gapdh or Tbp. Quantitative analyses were
performed independently at least three times and are shown
with standard error of the mean.
Immunochemistry
Immunocytochemistry was performed using mouse monoclonal
JA22 against CITED2 (AB5155, Abcam, Cambridge, United King-
dom, http://www.abcam.com/), goat anti-Nanog (AF2729, R&D
Systems, Abingdon, United Kingdom, http://www.rndsystems.
com/), and mouse monoclonal anti-H3triMek9 (AB8898,
Abcam) antibodies as previously described [22]. Western blot-
ting assays performed using 15–20 lg of whole cell lysates pre-
pared from mouse ESC as previously described [22]. Mouse
monoclonal JA22, goat anti-Nanog, rabbit polyclonal anti-Oct4
(AB19857, Abcam), and mouse monoclonal anti-ﬂagM2 (F1804,
Sigma, Steinheim, Germany, http://www.sigmaaldrich.com/por-
tugal.html) antibodies were used at 1:2,000 dilution. Loading
was monitored by probing the membrane with a mouse mono-
clonal anti-b-tubulin antibody (T5293, Sigma) used at 1:2,000
dilution.
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation (ChIP) experiments were per-
formed using mouse monoclonal JA22 against CITED2
(Abcam), anti-ﬂagM2 (Sigma), and mouse monoclonal anti-
cytochrome c (Abcam), as previously described [7]. DNA
enrichments were determined by qPCR using primers listed in
Supporting Information Table S1.
Transient Transfection Assays
E14TG2A cells were plated in gelatine-coated 24-well plates at
1.25 3 104 cells per well and transfected in duplicate the fol-
lowing day using Lipofectamine 2000 (Invitrogen). The pCITED2-
luc plasmid harboring the fragment 23,342 to 192 of the
human CITED2 promoter has been described elsewhere [23].
The pNanog-luc and pOct4-luc plasmids harboring the mouse
proximal Nanog promoter and the Oct4 promoter, respectively,
were described previously [24]. The LTBX3-luc plasmid harboring
the human TBX3 promoter has been previously described [25].
Cells were transfected with plasmids expressing ﬂag-CITED2
(pPyCAGIP-ﬂagCITED2), Nanog (pPyCAGIP-Nanog), or the control
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vector described elsewhere [13]. CMV-lacZ was cotransfected in
all experiments, and luciferase and b-galactosidase activities
measured 2 days post-transfection as previously described [22].
The ratio of luciferase to b-galactosidase was calculated to cor-
rect for variations in transfection efﬁciency.
Alkaline Phosphatase and Cell Proliferation Assays
Alkaline phosphatase (AP) assays, and determination of the
fraction (%) of stem cell colonies which corresponds to the
number of AP positive colonies over the total number of colo-
nies (AP-positive and -negative), were performed as previously
described [12]. For cell proliferation assays, ESC were plated
in gelatine-coated 12-well plates and counted at the indicated
time points. Population doubling per passage and cumulative
population doubling at each passage was calculated as
described previously [26].
Primary Reprogramming
Immortalized Cited2D/D MEFs were plated at the density of 5
3 104 per well in a six-well plate and transfected with the
PB-TAP-IRI-attP2LMKOSimO, PB-CA-rtTA, and HyPBase plasmids
[27], using XtremeGene HP reagent (Roche Applied Science,
Penzberg, Germany, http://lifescience.roche.com/). To initiate
reprogramming, culture medium was changed 24 hours after
transfection to ESC complete medium containing LIF (1,000 U/
ml), doxycycline (Dox, 1 lg/ml), vitamin C (10 lg/ml), and Alk
inhibitor (500 nM). Medium was replaced every 2 days. The
efﬁciency of the transfection was measured by analyzing the
mOrange expression 2 days after the addition of Dox. Alkaline
phosphatase (AP) assays were performed 15 days after the
addition of Dox.
Cited2 Overexpression in MKOS-Expressing MEFs
MEFs expressing the MKOS cassette and the Nanog-GFP
reporter were generated previously [27]. MEFs were trans-
duced with Cited2-MSCVneo retroviruses, and after 48 hours
the cells were mixed with wild-type MEF in a 1:10 ratio. A
total number of 1 3 105 cells were plated per well in a six-
well plate. The reprogramming was performed as described
above, and iPS colony formation was monitored using the
expression of mOrange and Nanog-GFP. AP staining and col-
ony counts were performed 20 days after the initiation of the
reprogramming.
Statistical Analysis
Statistical signiﬁcance was determined using two-tailed Stu-
dent’s t tests assuming unequal variance. p < 0.05 were con-
sidered statistically signiﬁcant.
RESULTS
Cited2 Is Required for ESC Proliferation, Survival,
and Self-Renewal
To determine the requirement for Cited2 in mouse ESC main-
tenance, we used a genetic loss-of-function approach. We
intercrossed Cited2ﬂ/ﬂ mice [20], and at the blastocyst stage,
we derived ESC (hereafter called C2ﬂ/ﬂ ESC) in which exon 2
of Cited2 is ﬂanked by LoxP sites. C2ﬂ/ﬂ ESC colonies main-
tained in culture with LIF supplementation showed a typical
ESC morphology, displayed alkaline phosphatase (AP) activity,
and expressed pluripotency markers (Fig. 1A and Supporting
Information Fig. S1A). Conversely, the removal of LIF or differ-
entiation by formation of embryoid bodies caused a cellular
morphology change, loss of AP activity, emergence of sponta-
neous beating foci, and a decrease of pluripotent markers
expression with a concomitant increase of differentiation
markers expression (Fig. 1A and Supporting Information Fig.
S1A, S1B). A recent study showed that Cited2-null ESC can
self-renew, but are affected in their differentiation capacities
[28]. To document such cells, we transiently transfected C2ﬂ/ﬂ
ESC with a Cre and green ﬂuorescent protein (GFP) coexpress-
ing plasmid, sorted highly GFP-positive ESC to enhance the
chances of deleting both Cited2 alleles, and allowed the cells
to grow in undifferentiating conditions for more than a
month. Although, most ESC showed an impairment of growth,
self-renewal and/or survival, within the ﬁrst 3 days following
Cited2 deletion, a few (i.e., 3%) able to self-renew were
genotyped as Cited2-null ESC, and expressed normal levels of
Nanog, Oct4, Sox2, Rex1, Klf4, Tbx3, and c-Myc (Supporting
Information Fig. S2). Therefore, as previously reported, a
minority of C2D/D ESC adapted to the loss of Cited2 and man-
aged to survive, but for the majority of the ESC, the early
response to acute loss of Cited2 expression was a substantial
reduction in their proliferation suggesting that Cited2 plays a
pivotal role in ESC maintenance and survival.
To further deﬁne the role of Cited2 in mouse ESC, we
generated C2ﬂ/ﬂ ESC that constitutively express tamoxifen-
inducible Cre (Cre-ERt) by stable transfection and isolated
three independent clones, named C2ﬂ/ﬂ[Cre]A, C2ﬂ/ﬂ[Cre]B,
and C2ﬂ/ﬂ[Cre]C. Since C2ﬂ/ﬂ[Cre]A, C2ﬂ/ﬂ[Cre]B, and C2ﬂ/ﬂ[Cre]C
presented indistinguishable behavior, for simplicity, they will
be referred to as C2ﬂ/ﬂ[Cre] ESC. The activation of Cre-ERt by
4-hydroxytamoxifen (4HT) treatment signiﬁcantly reduced
endogenous Cited2 expression within 48 hours in C2ﬂ/ﬂ[Cre]
ESC while Cited2 expression in C2ﬂ/ﬂ ESC was maintained at
levels similar to those of ethanol (vehicle) treated cells (Fig.
1B). Surprisingly, C2D/D[Cre] ESC also showed a concomitant
decrease in Nanog expression while the expression of other
pluripotency markers was unaffected compared to ethanol
treated cells (Supporting Information Fig. S1C). In addition,
C2D/D[Cre] ESC displayed impaired self-renewal capacity (Fig.
1C, 1D). Similarly, GFP-positive C2ﬂ/ﬂ ESC transiently trans-
fected with the Cre and GFP coexpressing plasmid showed
impaired growth, while 4HT or ethanol treatment of E14TG2A
ESC stably expressing Cre-ERt had no effect on their growth
ruling out a major nonspeciﬁc effect of the activated Cre-ERt
in our experimental conditions (Supporting Information Fig.
S1D, S1E). Moreover, morphological colony alterations and a
noticeable amount of cells detached from the plate were
observed in C2D/D[Cre] cultures (Fig. 1E), suggesting spontane-
ous differentiation, increased cell death, and/or decline of cell
adhesion. Staining of the adherent cells with Annexin V and
propidium iodide (PI) revealed statistically signiﬁcant differ-
ence in cell viability between C2D/D[Cre] and C2ﬂ/ﬂ[Cre] ESC
cultures (Fig. 1F). Conversely, cells ﬂoating in the culture
medium, 20 and 48 hours after addition of 4HT, were stained
by PI indicating their late apoptotic state and were two- to
fourfold more abundant in Cited2-knockout than control cul-
tures (Fig. 1G). Therefore, the decrease in cell proliferation
and diminished total number of Cited2-knockout cells in com-
parison to control cells, occurring as early as 48 hours after
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Figure 1. Mouse embryonic stem cells (ESC) require Cited2 for proliferation, survival, and pluripotency. (A): AP activity in C2ﬂ/ﬂ ESC cul-
tured on gelatine in the presence (top panel) or 4 days after removal (bottom panel) of LIF. (B): Expression of Cited2 transcripts deter-
mined by quantitative real-time PCR in C2ﬂ/ﬂ, and C2ﬂ/ﬂ ESC stably transfected with a Cre-ERt expressing plasmid, the ESC lines
C2ﬂ/ﬂ[Cre]A, C2ﬂ/ﬂ[Cre]B, and C2ﬂ/ﬂ[Cre]C, treated with 1 lM 4HT or ethanol (vehicle for 4HT) for 48 hours. Expression level is normal-
ized for Gapdh and reported as relative to the expression in C2ﬂ/ﬂ ESC treated with ethanol which is set at 1. Results are presented as
the mean6 SEM of three independent biological replicates (each performed in technical duplicate). (C): Proliferation of C2ﬂ/ﬂ[Cre]A,
C2ﬂ/ﬂ[Cre]B, and C2ﬂ/ﬂ[Cre]C ESC lines plated at 500 cells per well of gelatinized wells (12-well plate) in the presence of ethanol or 0.5
lM 4HT at day 0. Cells were maintained in culture with the conditions applied at day 0 until counted at the indicated time points.
Results are presented as the mean6 SEM of three biological replicates, each performed in technical duplicate. (D): Percentage of AP-
positive colonies over the total number of colonies at day 6 after ethanol or 4HT treatment in the presence of LIF. Results are the
mean6 SEM of three independent biological replicates (each performed in technical duplicate). (E): Representative morphology of con-
trol ESC (C2ﬂ/ﬂ[Cre]) and cells 3 days after Cited2 depletion by 4HT (C2D/D[Cre]). (F): Percentage of C2ﬂ/ﬂ[Cre] and C2D/D[Cre] adherent
ESC positive for Annexin V (early apopotosis) or propidium iodide (PI, late apoptosis) determined by ﬂow sorting anlysis (FACS) 20 or 48
hours after ethanol or 4HT treatment. (G): Total number of C2ﬂ/ﬂ[Cre] and C2D/D[Cre] ESC in the culture supernatants stained with PI,
20 and 48 hours after treatment with ethanol or 4HT, determined by FACS. Results in (F) and (G) are shown as the mean6 SEM of
three technical replicates performed with two biological replicates (i.e., C2ﬂ/ﬂ[Cre]A and C2ﬂ/ﬂ[Cre]B ESC). Abbreviations: AP, alkaline
phosphatase; CPD, cumulative population doublings; LIF, leukemia inhibitory factor.
inducing Cited2 deletion, results from enhanced differentia-
tion and/or increased death of cells lacking Cited2 expression.
To conﬁrm that the defects we observed in C2D/D
[Cre] ESC were speciﬁc to Cited2 deletion, we transduced
C2ﬂ/ﬂ[Cre]A and C2ﬂ/ﬂ[Cre]B ESC lines with a lentiviral vector
constitutively expressing GFP and the human CITED2 (with
95% homology to the mouse protein) which rescues devel-
opmental defects resulting from Cited2 deﬁciency [13]. For
simplicity, these cells will be referred to as C2ﬂ/ﬂ[Cre]/CITED2
ESC. We also developed C2ﬂ/ﬂ[Cre]/Control ESC expressing GFP
without exogenous CITED2. Since the data obtained using
C2ﬂ/ﬂ[Cre]A and C2ﬂ/ﬂ[Cre]B cell lines were very consistent,
they are presented as combined in this section. The activation
of Cre-ERt by 4HT treatment signiﬁcantly reduced endogenous
Cited2 expression in C2D/D[Cre]/Control ESC, while overall
CITED2 expression in C2ﬂ/ﬂ[Cre]/CITED2 and C2D/D[Cre]/CITED2
ESC was maintained at levels similar to those of ethanol
treated C2ﬂ/ﬂ[Cre]/Control ESC (Fig. 2A, 2B). Similarly to C2D/
D[Cre] cells, C2D/D[Cre]/Control ESC also showed a decreased
Nanog expression while the expression of other pluripotency
markers was unaffected compared to C2ﬂ/ﬂ[Cre]/Control ESC
(Fig. 2B). Like C2D/D[Cre] cells, C2D/D[Cre]/Control ESC displayed
impaired growth suggesting that lentiviral integration events
used to originate C2ﬂ/ﬂ[Cre]/Control did not alter C2ﬂ/ﬂ[Cre]
ESC properties (Fig. 2C). Similar effects were obtained with
medium supplemented with LIF, or LIF and inhibitors of MEK
and GSK3 (2i) which are essential for the maintenance of
ground state pluripotency of ESC [29], and with fetal bovine
serum from different providers (Fig. 2C and Supporting Infor-
mation Fig. S1H), suggesting that Cited2 is required for the sur-
vival of ESC in stringent naive conditions and its effects did not
vary with serum batches. In addition, C2D/D[Cre]/Control ESC
displayed reduced AP activity (Fig. 2D and Supporting Informa-
tion Fig. S1G). Importantly, both impaired growth and AP activ-
ity defects were rescued by ectopic expression of CITED2 in
C2D/D[Cre]/CITED2 ESC, indicating that they are speciﬁc to
Cited2 deletion. However, the constitutive expression of CITED2
did not completely rescue defective proliferation rates of C2D/
D[Cre] ESC to the level of control ESC expressing endogenous
Cited2. This suggests that ESC optimal proliferation requires
Cited2 expression driven by its endogenous promoter.
The cell-cycle analyses revealed that 48 hours after 4HT
treatment C2D/D[Cre]/Control ESC displayed a increase in G2/
M phase and a concomitant decrease in S phase compared to
C2D/D[Cre]/CITED2 ESC (Fig. 2E). Therefore, the decrease in
cell proliferation and diminished total cell number upon
Cited2 deletion may result from G2/M cell cycle arrest,
enhanced differentiation, and/or increased death of cells lack-
ing Cited2 expression. Overall, we unequivocally demonstrated
that the majority of Cited2-knockout ESC are substantially
compromised in their proliferation, self-renewal, and survival
within the ﬁrst 2–3 days of Cited2 deletion.
Spontaneous Differentiation of Cited2-Knockdown ESC
To corroborate our results obtained in C2D/D[Cre] ESC in dif-
ferent ESC line, we knocked down the expression of Cited2
in a previously established and extensively studied feeder-
independent E14TG2A ESC line [30, 31]. To silence Cited2
expression in E14TG2A ESC, we used a plasmid expressing a
double stranded RNA corresponding to 375 bp of the 50 of
the human CITED2 open reading frame (KD-Cited2). ESC
were also transfected with the empty vector (KD-empty) or
a vector expressing a 369 bp fragment (KD-control) of a
nontargeting double stranded RNA. In contrast to C2D/D[Cre]
ESC which were compromised in their survival, E14TG2A ESC
transfected with KD-Cited2 did not present apparent cell
death, although Cited2 expression was reduced to 15%–20%
of its normal expression 6 days after transfection (Fig. 3A,
3B). Conversely, Cited2-knockdown in E14TG2A ESC caused a
reduction of proliferation and a marked reduction of the
number of AP-positive colonies in comparison to cells trans-
fected with the control KD-empty or KD-control vectors (Fig.
3C, 3D and Supporting Information Fig. S1F). The decrease of
AP activity and the increase of histone H3K9 trimethylated
nuclear foci (Fig. 3E, 3F), a mark of ESC differentiation [32],
suggested a spontaneous differentiation of Cited2-
knockdown cells maintained in conditions sustaining an
undifferentiated state. The differentiation was further sup-
ported by the concomitant expression of differentiation
markers, such as Brachyury, Cdx2 (mesoderm), and Foxa2
(endoderm), while the expression of Gata6 and Sox17, extra-
embryonic endodermal markers, and Fgf5, primitive ectoder-
mal marker, was unaffected whereas Sox1 (deﬁnitive
ectoderm) expression was decreased in Cited2-knockdown
cells (Fig. 3G). Six days after Cited2-knockdown in E14TG2A,
the decrease of pluripotency markers expression such as
Oct4, Nanog, Tbx3, Lefty2, and Nodal was also observed,
conﬁrming further the differentiation of Cited2-knockdown
cells (Fig. 3G). However, the decrease of pluripotency gene
expression in Cited2-knockdown cells might result either
from a direct effect of Cited2-depletion or is a consequence
of the spontaneous differentiation process initiated by
Cited2-knockdown. Collectively, these observations demon-
strated that E14TG2A ESC with reduced levels of Cited2
expression were compromised in their ability to remain
undifferentiated in conditions supporting ESC self-renewal.
Cited2 Regulates Nanog Expression in Mouse ESC
Nanog and Cited2 were detected in ESC nuclei (Fig. 4A), and
their expression was concomitantly decreased in E14TG2A,
C2D/D[Cre], and C2D/D[Cre]/Control ESC 2 days after Cited2
depletion, while Oct4 expression was unaffected (Figs. 2B, 4B
and Supporting Information Fig. S1C). To determine whether
Cited2 directly controls the expression of Nanog, we tested
the recruitment of Cited2 to the Nanog promoter elements in
undifferentiated ESC by ChIP assay. A signiﬁcant enrichment
of the Nanog proximal promoter and the “Stat3-binding” ele-
ment was detected from extracts immunoprecipitated with
the anti-Cited2 antibody (Fig. 4C), revealing the presence of
endogenous Cited2 at these regulatory elements. No enrich-
ment of c-Myc promoter was detected with anti-Cited2 anti-
body suggesting that Cited2 is speciﬁcally recruited to the
Nanog elements. To investigate the effect of Cited2 overex-
pression in Nanog expression, we used E14/T ESC derived
from E14TG2A cells which express the polyoma large T protein
and permit the stable episomal expression of plasmids con-
taining the origin of DNA replication of the polyoma virus,
such as pPyCAGIP-derived plasmids [19]. In E14/T ESC forced
to express high levels of ﬂag-CITED2 and displaying enhanced
Nanog expression (Fig. 4E, 4F), we observed an augmented
recruitment of ﬂag-CITED2 to the proximal promoter of Nanog
when compared with endogenous Cited2 binding, suggesting
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a dose-dependent enrolment of Cited2 to the regulatory ele-
ments of Nanog (Fig. 4D). In reporter assays, we showed that
the Nanog proximal promoter activity was reduced by Cited2
depletion, while signiﬁcantly enhanced by expression of ﬂag-
CITED2 (Fig. 4G). In contrast, Cited2 depletion or overexpres-
sion had little or no effect on Oct4 promoter transcriptional
Figure 2. Cited2 knockout defects in embryonic stem cells (ESC) are rescued by human CITED2 expression. (A): C2ﬂ/ﬂ[Cre]A and
C2ﬂ/ﬂ[Cre]B ESC were transduced with a lentiviral vector constitutively expressing the human CITED2 or a control vector to generate
C2ﬂ/ﬂ[Cre]/CITED2 and C2ﬂ/ﬂ[Cre]/Control, respectively. Cited2 protein levels were detected by Western blotting in extracts from
C2ﬂ/ﬂ[Cre]/Control, C2ﬂ/ﬂ[Cre]/CITED2, C2D/D[Cre]/Control, and C2D/D[Cre]/CITED2 ESC 48 hours after incubation with ethanol or 4HT.
Loading in each lane was monitored by detection of b-tubulin. (B): Relative expression of Cited2 and pluripotency markers in cells
described in (A). Gene expression in C2ﬂ/ﬂ[Cre]/Control ESC was set to 1. Results are presented as the mean6 SEM of technical tripli-
cates performed using two independent biological replicates (i.e., C2ﬂ/ﬂ[Cre]A and C2ﬂ/ﬂ[Cre]B ESC). (C): CPD of cells as described in A
(LIF) or further supplemented with 1 lM PD0325901 and 3 lM CHIR99021 (LIF12i), after treatment with ethanol or 4HT for 24 hours.
Cells were plated at 10,000 cells per gelatinized well of a six-well plate at day 0. Results are presented as the mean6 SEM of three
independent experiments performed with C2ﬂ/ﬂ[Cre]B ESC. (D): Percentage of AP-positive colonies over the total number of colonies in
C2ﬂ/ﬂ[Cre]/Control, C2D/D[Cre]/Control, C2ﬂ/ﬂ[Cre]/CITED2, and C2D/D[Cre]/CITED2 ESC cultures 6 days after ethanol or 4HT treatment.
Results are presented as the mean6 SEM of technical triplicates performed in two independent biological replicates. (E): FACS analysis
of the indicated ESC cell cycle proﬁle by propidium iodide staining. Data are the mean6 SEM of three independent experiments per-
formed with C2ﬂ/ﬂ[Cre]/Control, C2D/D[Cre]/Control, C2ﬂ/ﬂ[Cre]/CITED2, and C2D/D[Cre]/CITED2 ESC. Abbreviations: AP, alkaline phospha-
tase; CPD, cumulative population doublings; LIF, leukemia inhibitory factor.
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Figure 3. Cited2 knockdown results in spontaneous differentiation in embryonic stem cells. (A): Relative Cited2 gene expression in
E14TG2A cells detected by quantitative real-time PCR (qPCR), 6 days post-transfection of a vector expressing a double stranded RNA target-
ing Cited2 (KD-Cited2), a nontargeting double stranded RNA (KD-control), and the empty (KD-empty) vectors. Cited2 expression in E14TG2A
cells with the empty vector is set to 1. Results are presented as the mean6 SEM of three independent experiments performed in technical
triplicates. (B): Cited2 protein levels detected in E14TG2A extracts with anti-Cited2 antibody by Western blotting. Equal loading in each
lane was monitored by b-tubulin detection. (C): Proliferation of E14TG2A cells transfected with KD-empty, KD-control, or KD-Cited2 vectors.
Cells were plated at 500 cells per gelatinized wells (12-well plate) the day after transfection. Cells were maintained in culture under the
conditions applied at day 0 until counted at the indicated time points. Results are presented as the mean6 SEM of three independent
experiments, each performed in technical duplicate. (D): Percentage of AP-positive colonies over the total number of colonies, 5 days post-
transfection of E14TG2A cells with KD-empty, KD-control, or KD-Cited2 vectors. Results are presented as the mean6 SEM of three biologi-
cal experiments. (E): KD-control or KD-Cited2 transfected E14TG2A cells coimmunostained with anti-Cited2 (green), anti-H3-triMeK9 (red)
antibodies, and DAPI (blue). Arrow heads indicate cells with undetectable Cited2 protein, with enlarged nuclei and increased number of
H3-triMeK9 foci. (F): Distribution of H3-triMeK9 foci number in KD-control or KD-Cited2 transfected cells described in (E). The results are
presented as cluster of cells displaying up to 10 (0–10), between 11 and 20 (11–20), and more than 21 H3-triMeK9 foci in KD-control
(black bars) and all KD-Cited2 (white bars) transfected cells. The number of H3-triMeK9 in KD-Cited2 transfected cells expressing high levels
of Cited2 (red bars) and low levels or no detected Cited2 (gray bars) is also presented. (G): Transcript levels of pluripotency (black bars),
mesoderm (Brachyury, Cdx2), endoderm (Foxa2, Gata6, Sox17), ectoderm (Fgf5, Sox1) markers, and Cited2 (gray bar) detected by qPCR
using the primer set Cited2#2 (Supporting Information Table S1) in E14TG2A cells 6 days post-transfection of KD-empty or KD-Cited2. Gene
expression presented as fold of expression relative to KD-empty treated cells. Data are the mean6 SEM of three independent experiments,
each performed in technical triplicate. Abbreviation: AP, alkaline phosphatase.
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activity, which is in line with the lack of enrichment of the
Oct4 regulatory elements in ChIP assays with anti-Cited2 anti-
body (Fig. 4C, 4H), indicating further that Nanog is a speciﬁc
Cited2 target gene. Overall, our results indicated that in undif-
ferentiated mouse ESC, Cited2 directly stimulates Nanog
expression by acting positively on Nanog promoter, and sug-
gest that the decrease in Oct4 expression occurring in ESC
after prolonged Cited2 depletion (Fig. 3G) is an indirect
Figure 4.
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consequence of Nanog downregulation and/or a result of
spontaneous differentiation.
Cited2 Modulates the Expression of Tbx3 and Klf4 in
Mouse ESC
CITED2 overexpression in E14/T ESC also increased Sox2, Klf4,
and Tbx3 expression (Fig. 4E), whereas Cited2 depletion resulted
in a signiﬁcant decrease of Klf4 and Tbx3 expression (Figs. 3G,
6G). Using ChIP assays, we showed that endogenous Cited2 was
present at the distal region of the Klf4 promoter (Fig. 5), which
is homologous to the previously identiﬁed CITED2-responsive
region of the human KLF4 promoter [33]. The recruitment of
ﬂag-CITED2 at the Klf4 locus correlated with the increase of the
endogenous Klf4 expression in E14/T cells overexpressing ﬂag-
CITED2. The presence of Cited2 was also detected at the proxi-
mal promoter and the 30 end of the ﬁrst exon of the Tbx3
locus, and ﬂag-CITED2 overexpression stimulated the transcrip-
tional activity of the human TBX3 promoter in reporter assays
(Fig. 5B, 5D). Therefore, Tbx3 and Klf4 are direct downstream
targets of Cited2 in ESC, suggesting that Cited2 supports LIF-
activated PI3K/AKT/Tbx3/Nanog and Jak/Stat3/Klf4/Sox2 path-
ways that are critical for mouse ESC maintenance [2, 3].
Ectopic Nanog Expression Bypasses Defects Caused by
Cited2 Depletion
Previous studies indicated the presence of NANOG at the
endogenous CITED2 promoter in human ESC [14]. Concordantly,
we showed that Nanog stimulated the human CITED2 promoter
activity (Fig. 6A). These observations, together with the data
showing that Cited2 also acts upstream of Nanog, suggest a
complex reciprocal interaction between Nanog and Cited2. To
explore the epistatic relationship between Cited2 and Nanog,
we asked whether forced expression of Nanog can restore nor-
mal ESC functions of Cited2-knockdown cells. Indeed, Cited2-
knockdown E14/T ESC constitutively expressing Nanog gener-
ated signiﬁcantly higher numbers of AP-positive colonies and
had increased growth rate compared to Cited2-knockdown
E14/T-vector cells (Fig. 6B–6E). However, in line with the
reporter assays, Nanog overexpression increased Cited2 expres-
sion in E14/T-Nanog cells (Fig. 6D). Moreover, the ectopic
expression of Nanog in these conditions is higher than endoge-
nous control levels even in Cited2-knockdown ESC. Thus, to ver-
ify whether Nanog can autonomously rescue the defects in
absence of Cited2, we engineered C2ﬂ/ﬂ ESC stably expressing
Nanog (C2ﬂ/ﬂ/Nanog ESC) at levels comparable to those of con-
trol cells (C2ﬂ/ﬂ/Control ESC), and deleted Cited2 by transfecting
a Cre-expressing plasmid, which per se did not perturb cellular
growth of ESC (Supporting Information Fig. S1D). Cited2 dele-
tion impaired the proliferation of control cells, C2D/D/Control
ESC, but not Cited2-deﬁcient C2D/D/Nanog ESC (Fig. 6F). As
expected, Cited2 deletion in C2D/D/Control ESC caused a signiﬁ-
cant decrease of Cited2 and Nanog expression compared to
the control C2ﬂ/ﬂ/Control cells 4 days after the transfection of
the Cre-expressing plasmid (Fig. 6G). A concomitant decrease
of Klf4 expression was observed in C2D/D/Control ESC, 4 days
after the transfection of the Cre-expressing plasmid, that was
not observed in C2D/D [Cre]/Control ESC 2 days after Cited2-
knockout (Fig. 2B). Ectopic Nanog expression in Cited2-null ESC
restored Nanog expression levels and increased c-Myc expres-
sion. Conversely, Klf4 expression remained low in Nanog-
rescued cells, which is in line with previous reports that
showed that Klf4 is not a direct target of Nanog [34], and sug-
gesting that Cited2 activates Klf4 expression in a Nanog-
independent manner. Therefore, our results showed that Cited2
and Nanog may be part of a feed-forward transcriptional loop
required for ESC self-renewal, and the defects caused by Cited2
depletion are, at least in part, due to Nanog downregulation.
Cited2 Is Required for and Enhances Reprogramming
of MEFs into iPS Cells
Having demonstrated the requirement for Cited2 in the mainte-
nance of ESC self-renewal, we next wanted to establish its role
in the induction of the pluripotent state. To circumvent prema-
ture senescence caused by Cited2 deﬁciency in primary MEFs
[26], we immortalized Cited2ﬂ/ﬂ;Rosa26CreERT2 and Cited2ﬂ/ﬂ
(or Cited21/1;Rosa26CreERT2) control MEFs by serial passaging
and then treated them with 4HT (Fig. 7A). To deliver Myc, Klf4,
Oct4, and Sox2 (MKOS factors) to MEFs we used a piggyBac
(PB) transposon-based primary reprogramming system [27].
Brieﬂy, Cited2D/D and control MEFs were transfected with PB
transposon carrying a doxycycline-inducible MKOS-IRES-mOr-
ange cassette, a constitutively active CAG-rtTA transactivator
construct and a transposase expression vector [27]. The expres-
sion of the MKOS factors and mOrange was activated by the
Figure 4. Cited2 controls Nanog expression. (A): Immunocytochemistry using anti-Cited2 (green), anti-Nanog (red) antibodies, and DAPI
(blue) in E14TG2A. (B): Cited2, Nanog, and Oct4 protein levels detected in E14TG2A extracts prepared 48 hours post-transfection with
KD-control or KD-Cited2. Loading in each lane was monitored by detection of b-tubulin. (C): Top: diagram of the mouse Nanog genomic
contig showing the transcriptional start site (arrow), exon 1 (gray box), and the positions of PCR primers (arrow heads) used in chroma-
tin immunoprecipitation (ChIP) assays. Bottom: enrichment analyzed by quantitative real-time PCR (qPCR) of the “Stat3” element, the
distal enhancer and the proximal promoter of Nanog, as well as the CR1 proximal promoter and the CR4 distal enhancer of Oct4, and c-
Myc proximal promoter in ChIP assays using anti-Cited2 and control anti-ﬂag antibodies. Results are presented as the mean6 SEM of
three independent experiments. (D): Enrichment of Nanog proximal promoter from E14/T cells expressing ﬂag-CITED2 or control vector
in ChIP assays using anti-ﬂag or control antibodies. Results are presented as the mean6 SEM of three biological experiments. (E):
Endogenous Nanog, Oct4, Sox2, Klf4, Tbx3, c-Myc, and ectopic CITED2 transcript levels detected by qPCR in E14/T cells transfected with
pPyCAGIP or pPyCAGIP-ﬂagCITED2. Expression is presented as fold relative to pPyCAGIP. Results are shown as the mean6 SEM of three
independent experiments. (F): Ectopic ﬂag-CITED2 and endogenous Nanog protein levels in E14/T embryonic stem cells (ESC) transfected
with pPyCAGIP or pPyCAGIP-ﬂagCITED2 detected by Western blotting. Loading in each lane was monitored by detection of b-tubulin.
(G): Left panel: pNanog-luc or pGL3basic activity in E14TG2A cells cotransfected with KD-Cited2 (gray bars) or KD-empty (black bars).
RLU are presented relative to RLU of pGL3basic transfected with the control vector KD-empty set at 1. Right panel: pNanog-luc or
pGL3basic activity in E14TG2A cells cotransfected with pPyCAGIP-ﬂagCITED2 (gray bars) or pPyCAGIP (black bars). Results are presented
as the mean6 SEM of three biological experiments performed in duplicate. (H): pOct4-luc or pGL3basic activity in E14TG2A ESC cotrans-
fected as in (G). Results are presented as the mean6 SEM of three independent experiments (each performed in technical duplicate).
Abbreviation: RLU, relative luminescence units.
Kranc, Oliveira, Armesilla-Diaz et al. 707
www.StemCells.com VC 2015 The Authors. STEM CELLS Published by
Wiley Periodicals, Inc. on behalf of AlphaMed Press
addition of doxycycline to the culture medium. The frequency
of mOrange positive MEFs was measured by ﬂow cytometry at
day 2 after transfection and the initiation of doxycycline treat-
ment revealed a similar expression in Cited2 knockout and con-
trol MEFs (Fig. 7B). We found that 15 days after the initiation
of the reprogramming process the number of colonies express-
ing the early reprogramming marker AP was drastically reduced
in Cited2D/D cultures compared to control cultures (Fig. 7C).
The expression of endogenous Nanog in colonies arising from
control MEFs was veriﬁed by immunoﬂuorescence, demonstrat-
ing efﬁcient reprogramming of control MEFs (Fig. 7D). Finally,
the results obtained in Cited2D/D MEFs were corroborated
using primary MEFs with shRNA-mediated Cited2 knockdown
(not shown). Therefore, Cited2 is critically required for MEF
reprogramming to iPS cells.
We next asked whether Cited2 can increase the efﬁciency
of iPS generation. For this purpose, we used secondary reprog-
ramming system in which all MEFs harbor a doxycycline-
inducible MKOS cassette and the expression of MKOS can be
monitored by an mOrange reporter [27]. This system also har-
bors the Nanog-eGFP reporter that allows detecting the activa-
tion of the endogenous Nanog promoter. For simplicity, these
MEFs will be referred to as MKOS-MEFs. To test the impact of
Cited2 on reprogramming, we transduced MKOS-MEFs with
MSCV retroviruses expressing Cited2 or empty control retrovi-
ruses, and simultaneously added doxycycline to these cultures.
We found that Cited2 overexpression in MKOS-MEFs promoted
an early emergence of Nanog-eGFP positive colonies in compari-
son to the control cells (Fig. 7E), and increased the total num-
ber of colonies expressing AP (Fig. 7F). These ﬁndings taken
together imply that Cited2 is required for reprogramming of
MEFs to iPS cells, can accelerate the emergence of Nanog posi-
tive cells, and enhances the frequency of iPS cell generation.
DISCUSSION
Taken together, the prime effect of Cited2 depletion in
E14TG2A, E14/T, and newly derived ESC lines was the impair-
ment of self-renewal, proliferation, cell survival, and increased
spontaneous differentiation. Amongst the core pluripotency
genes assessed, only Nanog expression was affected as early
as 48 hours after Cited2 depletion. We demonstrated that
Nanog, Klf4, and Tbx3 are direct target genes of Cited2 and
Nanog constitutive expression rescued the cellular defects
caused by Cited2 depletion, suggesting that these defects are,
at least in part, the consequence of reduced expression of
Nanog (Fig. 7G). Indeed, Nanog is a molecular gatekeeper sup-
pressing spontaneous differentiation of ESC, which is essential
for the pluripotency gene regulatory network stability and
prolonged decrease of its expression secures cell fate commit-
ment [35]. Moreover, Nanog depletion triggers stochastic
early changes in ESC gene expression [35], which might
account for some inconsistency observed in the expression of
pluripotency related genes such as Klf4 or Tbx3 when we
Figure 5. Cited2 is present at the Klf4 and Tbx3 promoters in embryonic stem cells (ESC). (A): Diagram of the mouse Klf4 and Tbx3
genomic contigs showing the transcriptional start site (arrow), exon 1 (gray box), and the positions of PCR primers (arrow heads) used
in chromatin immunoprecipitation (ChIP) assays. The region of mouse Klf4 promoter responsive to Cited2 overexpression in epithelial
cells determined elsewhere is indicated by brackets. (B): Enrichment of the promoter region of Klf4 (Klf4 A and B), the junction of intron
1 and exon 2 of Klf4 (Klf4 C), the distal (Tbx3 A), proximal promoter (Tbx3 B), and the junction of exon 1 and intron 1 of Tbx3 (Tbx3 C)
in ChIP assays with anti-Cited2 compared to control antibodies. (C): ChIP assays using anti-ﬂag or control antibodies as described above
with Klf4 primers in E14/T expressing ﬂag-CITED2 or control vector. (D): LTBX3-luc or pGL3basic activity in E14TG2A ESC cotransfected as
in Figure 4G. Data are the mean6 SEM of three independent experiments (each performed in technical duplicate). Results in (B) and
(C) are presented as the mean6 SEM of three independent biological experiments. Abbreviation: RLU, relative luminescence units.
708 Cited2 Regulates Nanog Expression
STEM CELLSVC 2015 The Authors. STEM CELLS Published by
Wiley Periodicals, Inc. on behalf of AlphaMed Press
Figure 6. Nanog overexpression rescues defects caused by knockdown of Cited2. (A): pCITED2-luc or pGL3basic activity in E14TG2A
embryonic stem cells (ESC) cotransfected with pPyCAGIP (black bars) or pPyCAGIP-Nanog (gray bars). RLU are presented relative to RLU
of pGL3basic transfected with the control vector pPyCAGIP set at 1. Results are shown as the mean6 SEM of three independent experi-
ments. (B): Percentage of AP-positive colonies over the total number of colonies in E14/T-vector and E14/T-Nanog cells transfected with
KD-control or KD-Cited2 vectors. Results are presented as the mean6 SEM of three biological experiments. (C): Proliferation of E14/T-
vector and E14/T-Nanog treated as in (B). Results are presented as the mean6 SEM of three independent experiments. (D): Nanog and
Cited2 transcript levels detected by quantitative real-time PCR (qPCR) in E14/T-vector or E14/T-Nanog cells transfected for 48 hours KD-
control or KD-Cited2. Gene expression is presented relative to expression in E14/T-vector (which is set at 1). Results are presented as
the mean6 SEM of three independent experiments. (E): Cited2 and Nanog protein levels in E14/T-vector or E14/T-Nanog cell extracts.
Equal loading in each lane was monitored by b-tubulin detection. (F): Proliferation of C2ﬂ/ﬂ/Control or C2ﬂ/ﬂ/Nanog ESC as well as
C2D/D/Control and C2D/D/Nanog ESC isolated 48 hours post-transfection of a Cre and green ﬂuorescent protein (GFP) expressing plasmid.
Sorted GFP1 cells were plated at 10,000 cells per gelatinized wells (six-well plate) at day 0. Results are presented as the mean6 SEM of
three independent experiments. (G): Cited2, Nanog, Oct4, Sox2, Rex1, Tbx3, Klf4, and c-Myc transcript levels detected by qPCR from
C2ﬂ/ﬂ/Control, C2ﬂ/ﬂ/Nanog, C2D/D/Control, and C2D/D/Nanog GFP-positive cells puriﬁed by FACS, 4 days post-transfection of a Cre and
GFP coexpressing plasmid. Data are the mean6 SEM of three independent experiments. Abbreviations: AP, alkaline phosphatase; CPD,
cumulative population doublings; RLU, relative luminescence units.
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Figure 7. Cited2 is essential for the generation of induced pluripotent stem cells and enhances the efﬁciency of reprogramming. (A):
Relative expression of Cited2 mRNA in control (MEF-C2ﬂ/ﬂ[Cre]) and Cited2D/D (MEF-C2D/D[Cre]) MEFs measured by quantitative real-
time PCR using the Cited2#3 primer set and normalized to Tbp expression (Supporting Information Table S1). (B): mOrange expression
in control and Cited2D/D MEFs 2 days after transfection of PB transposon harboring MKOS-IRES-mOrange cassette, a constitutively active
CAG-rtTA transactivator construct and a transposase expression vector. (C): AP staining following 15 days in culture in the presence of
doxycycline. (D): Nanog expression in primary colonies 15 days after doxycycline treatment. (E): MEFs harboring a doxycycline-inducible
MKOS-IRES-mOrange cassette and Nanog-eGFP reporter (MKOS-MEFs) were transduced with MSCV retroviruses expressing Cited2 or
empty control retroviruses and treated with doxycycline. MKOS-MEFs transduced with Cited2 and control retroviruses are referred to as
MKOS-MEFs-Cited2 and MKOS-MEFs-Control, respectively. (F): AP staining in MKOS-MEFs-Cited2 or MKOS-MEFs-Control cultures 20 days
after the initiation of doxycycline treatment. (G): Model of direct (red) and indirect (gray) interactions between Cited2 and core pluripo-
tency. Results in (A), (C), and (F) are presented as the mean6 SEM of three independent experiments with at least two different biolog-
ical replicates. Abbreviations: AP, alkaline phosphatase; MEF, mouse embryonic ﬁbroblast.
modulated Cited2 expression levels, since we demonstrate
that Nanog is directly regulated by Cited2. Cited2 knockdown
led to the spontaneous differentiation of E14TG2A ESC, and in
addition to Nanog, a decrease of pluripotency markers such
as Oct4 was observed at day 6, but not at day 2 after Cited2
depletion, suggesting that Oct4 downregulation might result
from ESC differentiation rather than a direct effect of Cited2
on Oct4 expression. However, a deeper understanding of
Oct4-Cited2 reciprocal regulation might be of interest since an
inverse correlation of expression has been reported between
these factors [28, 36]. Moreover, our results also suggest that
the levels of Cited2 expression inﬂuence ESC fate. Indeed,
while a decrease in Cited2 expression may favor ESC differen-
tiation (as observed in E14TG2A ESC Cited2 knockdown), a
lack of Cited2 expression may compromise ESC viability (as
demonstrated in Cited2 knockout ESC).
Although the immediate effect of Cited2 deletion in ESC is
the loss of their self-renewal capacity, a recent study has
characterized Cited2-null ESC obtained by in vitro homologous
recombination from a Cited2 heterozygous ESC line [28]. We
were also able to expand Cited2-deﬁcient ESC that adapted to
culture upon serial passaging. In contrast to the phenotypes
we obtained upon acute loss of Cited2, Cited2-null ESC previ-
ously reported by Li et al. [28] showed normal self-renewal
capacity in the presence of LIF and differentiation defect
upon removal of LIF. This discrepancy might have come from
the selection process, in which only a small number of cells
that have bypassed the survival and self-renewal defects
adapted to culture and expanded after deletion of Cited2. A
comparable situation occurs when Nanog is depleted in ESC
expressing low levels of endogenous Nanog [37]. Indeed,
although Nanog-deﬁcient ESC are overtly prone to differentia-
tion, undifferentiated ESC lacking Nanog persist upon continu-
ous passaging and expresses normal levels of pluripotency
markers. Variations in Cited2 expression and its impact on
feedback loops, ESC heterogeneity, and cell fate commitment
that are Nanog-dependent [35] merit further investigations.
In this study, we have also demonstrated that Cited2 is
important for MKOS-mediated reprogramming of MEFs to iPS
cells. When and how Cited2 plays pivotal roles during reprog-
ramming remains to be identiﬁed. Given that in the primary
reprogramming experiments we used immortalized Cited2-deﬁ-
cient MEFs that have bypassed senescence pathways, senes-
cence is an unlikely explanation for their inability to undergo
reprogramming. Considering that Nanog is important for efﬁ-
cient reprogramming [38, 39], it is likely that Cited2 is involved
in Nanog-dependent pathways during MKOS-mediated genera-
tion of iPS cells. Furthermore, we demonstrated that Cited2 is
required for and directly enhances the expression of Tbx3 [40],
a transcription factor that accelerates reprogramming into iPS
cells. These data, taken together with our observations indicat-
ing that Cited2 accelerates and increases the efﬁciency of
reprogramming, suggest that one function of Cited2 is to con-
trol Nanog and Tbx3 expression during iPS cell generation.
CONCLUSION
Collectively, we demonstrate that Cited2 is a key regulator of
ESC survival and self-renewal. We also show that Cited2 is a
key component of the transcriptional regulatory network
emphasizing Nanog, Tbx3, and Klf4 expression by directly
binding the gene loci. Our data, together with Cited2 sufﬁ-
ciency to maintain undifferentiated ESC [12, 13], and its
requirement for hematopoietic stem cell maintenance [10, 11]
highlight the importance of Cited2 as a master regulator of
adult and ESC fates.
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